Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
300255.SZ Stock Price Chart
Explore Hebei Changshan Biochemical Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300255.SZ price movements and trends.
300255.SZ Company Profile
Discover essential business fundamentals and corporate details for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Aug 2011
Employees
1.41K
Website
https://www.heparin.cnCEO
Hao Cai
Description
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.
300255.SZ Financial Timeline
Browse a chronological timeline of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at ¥0.00 , while revenue for the quarter reached ¥258.70M .
Earnings released on 31 Dec 2024
EPS came in at -¥0.28 , while revenue for the quarter reached ¥246.79M .
Earnings released on 30 Sept 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥216.25M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥270.55M .
Earnings released on 20 May 2024
EPS came in at -¥0.07 , while revenue for the quarter reached ¥294.32M .
Earnings released on 31 Dec 2023
EPS came in at -¥0.95 , while revenue for the quarter reached ¥270.82M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.25 , while revenue for the quarter reached ¥319.24M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.17 , while revenue for the quarter reached ¥318.45M .
Dividend declared on 27 Jun 2023
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 27 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.00 , while revenue for the quarter reached ¥501.92M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.08 , while revenue for the quarter reached ¥542.45M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥647.28M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥572.32M .
Dividend declared on 2 Jun 2022
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 2 Jun 2022.
Earnings released on 29 Apr 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥574.18M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥809.61M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥741.04M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥706.93M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥710.47M .
Earnings released on 31 Dec 2020
EPS came in at ¥0.05 , while revenue for the quarter reached ¥726.17M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.08 , while revenue for the quarter reached ¥627.76M .
300255.SZ Stock Performance
Access detailed 300255.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.